Cite
HARVARD Citation
Said, J. et al. (2022). Topical tofacitinib for the management of lymphocytic‐variant hypereosinophilic syndrome with cutaneous involvement. Dermatologic therapy. 35 (7), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Said, J. et al. (2022). Topical tofacitinib for the management of lymphocytic‐variant hypereosinophilic syndrome with cutaneous involvement. Dermatologic therapy. 35 (7), p. n/a. [Online].